Sun, Dec 21, 2014, 6:18 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • longfcel longfcel Apr 23, 2013 8:05 AM Flag

    New scenario..... NCE worth zero.... and most bigholders in past months feared for an ANCHOR NDA denial

    What about that?
    Not all NDA are accepted.
    In this scenario, a big investor would have lost his pants.
    In this scenario - now NDA got acceptance - the Company gain 2x / 10x its value.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think that's potential gain. If it was prior to launch, it would be a bigger value swing. After launch though, it's primarily about earnings/scripts. This gives the potential for huge income/scripts, and once approved should quickly increase both. At this point, it gives investors more upside potential / less downside risk.

      Sentiment: Strong Buy

    • you lost your butt in affy now your here

      • 1 Reply to diejour_44
      • Hey there......
        I lost 80% of my gain in AFFY. Sold almost every Biostock.
        I saved AMRN & EXEL... my last bets on Biostocks.
        I swear myself not to look more Biostock.... anymore.
        Not only you have to dig deep to understand.... compare..... in a field where you can get only a part of it, unless you're a Doc (and I'm not).

        With AFFY, I discovered how a Company with a great drug can screw its shareholders as well.
        I tell you.... Omontis will sell Billions...... 0.02% in fatal events.... 25k patients.... no sense in what I've seen.... the FDA neither ask for a recall.!!!!
        The management (AFFY's) is croock... sold the whole Company's value.
        They will meet themselves in a hole.... sooner or later, after the trials.

 
AMRN
1.13+0.08(+7.62%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.